logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Adalimumab/azathioprine/infliximabTuberculosis reactivation: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2020年 / 1800卷 / 1期
关键词:
D O I:
10.1007/s40278-020-77377-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:15 / 15
相关论文
共 50 条
  • [31] InfliximabTuberculosis: case report
    Reactions Weekly, 2005, 1053 (1) : 12 - 12
  • [32] InfliximabTuberculosis: case report
    Reactions Weekly, 2004, 1018 (1) : 10 - 11
  • [33] InfliximabTuberculosis: case report
    Reactions Weekly, 2016, 1626 (1) : 96 - 96
  • [34] InfliximabTuberculosis : case report
    Reactions Weekly, 2023, 1984 (1) : 271 - 271
  • [35] InfliximabTuberculosis: case report
    Reactions Weekly, 2017, 1668 (1) : 224 - 224
  • [36] Adalimumab/azathioprine/ciclosporinSquamous cell carcinoma: case report
    Reactions Weekly, 2018, 1703 (1) : 19 - 19
  • [37] Adalimumab/azathioprine/ceftriaxoneLegionellosis and lack of efficacy: case report
    Reactions Weekly, 2023, 1963 (1) : 23 - 23
  • [38] InfliximabTuberculosis: case report
    Reactions Weekly, 2009, 1271 (1) : 22 - 22
  • [39] Azathioprine/tofacitinibHepatitis-B reactivation: case report
    Reactions Weekly, 2020, 1793 (1) : 90 - 90
  • [40] Adalimumab/infliximabHepatitis B virus reactivation: case report
    Reactions Weekly, 2015, 1578 (1) : 16 - 16
← 12345 →